Company Filing History:
Years Active: 2010
Title: Kiyotaka Watanabe: Innovator in Liver Cancer Prognosis
Introduction: Kiyotaka Watanabe is a prominent inventor based in Bunkyo-ku, Japan. He has made significant contributions to the field of medical technology, particularly in the area of liver cancer treatment and prognosis. His innovative approach has the potential to improve patient outcomes and enhance the understanding of cancer recurrence.
Latest Patents: Watanabe holds a patent for a method that predicts and judges the recurrence of liver cancer after treatment. This method is characterized by measuring GPC3 contained in a test sample using an anti-GPC3 antibody. This innovative technique offers a promising avenue for prognosing possible recurrence after liver cancer treatment.
Career Highlights: Throughout his career, Kiyotaka Watanabe has been associated with Perseus Proteomics Inc., where he has focused on advancing cancer research and diagnostics. His work has garnered attention for its potential impact on patient care and treatment strategies.
Collaborations: Watanabe has collaborated with notable colleagues in his field, including Shin Ohnishi and Hiroyuki Aburatani. These partnerships have contributed to the development of innovative solutions in cancer prognosis and treatment.
Conclusion: Kiyotaka Watanabe's contributions to liver cancer prognosis through his patented method exemplify the importance of innovation in medical research. His work continues to pave the way for advancements in cancer treatment and patient care.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.